Dr Anshuman Malaviya

Rheumatologist in Chelmsford y Cambridgeshire

MBBS MD FRCP(Rheum)

GMC: 6100700

31 Valoraciones de pacientes Valorar al doctor

Call

Book online

Telemedicine

Call

Book online

Telemedicine

Dr Anshuman Malaviya areas of expertise:

Professional statement

Dr Anshuman Malaviya is a Consultant Rheumatologist and is Clinical Lead of the rheumatology department at Addenbrooke’s Hospital in Cambridge. He specialises in the diagnosis and management of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, cancer immunotherapy-associated arthritis and manages patients with osteoporosis, vasculitis, fibromyalgia, and lupus .

Dr Malaviya qualified in 1998. Having done an MD and trained in general medicine as a junior doctor, he went on to do specialist training in rheumatology in the East of England. During this time, he spent 2 years in Cambridge and gained considerable clinical trial experience. He completed his specialist training in rheumatology and general medicine in 2012. He subsequently became a substantive NHS consultant at Mid Essex Hospital Trust in Chelmsford in 2012. Since 2017 he has been a consultant rheumatologist at Addenbrooke’s Hospital in Cambridge, where in addition to general clinics he also runs an Early Arthritis Clinic.

Dr Malaviya has gained considerable clinical experience during his time as a consultant, managing complex musculoskeletal disease and has developed an appreciation of the psychosocial impact chronic disease and pain has on the lives of both patients and their families. There is growing evidence that many autoimmune diseases present in clusters across various body systems such as the gut, the spine and the joints. Therefore, he takes a holistic approach - taking into account the body as a whole - when making his diagnoses and offering treatments. He strongly believes that appropriate early intervention can prevent long term chronic disease and disability.

Dr Malaviya is currently Clinical Lead of the Department of Rheumatology at Addenbrooke's Hospital. Over his career, he has won various awards including the Clinical Excellence Award Trust in 2014 and his rheumatology research team in Chelmsford won the CLRN Award for Best Research Team. He also routinely publishes in peer-reviewed journals.

Reviews

Treatments

Articles

Diplomas y publicaciones

Images

Videos

Doctor's articles

Credentials

GMC: ‍6100700

Professional experience

• More than 25 years of experience
• Consultant Rheumatologist and Clinical Lead, Cambridge University Hospitals NHS Foundation Trust (2017 - present)
• Consultant Rheumatologist, Spire Cambridge Lea Hospital (present)
• Consultant Rheumatologist, Springfield Hospital, Chelmsford (present)
• Rheumatology Clinical Research Fellow, Cambridge Univesity Hospitals NHS Foundation (2011 - present)
• Rheumatology Registrar, Addenbrooke's University Hospital (2010 - 2011)

...

Sub-specialties

• Inflammatory back pain
• Rheumatoid arthritis
• Inflammatory bowel disease associated arthritis
• Tendonitis
• Steroid joint injections
• Ehlers Danlos Syndrome
• Inflammatory musculoskeletal conditions
• Joint injections
• Cancer-immunotherapy associated arthritis

...

Teaching posts

• Clinical supervisor for rheumatology trainees in Cambridge

Education

• Distinction in Biochemistry
• Clinical Supervisor for rheumatology trainees at Addenbrooke's Hospital, Cambridge

Publications and conferences

• (Research Collaboration). Holroyd CR, Seth R, Bukhari M, Malaviya A, Holmes C, Curtis E, Chan C, Yusuf MA, Litwic A, Smolen S, Topliffe J, Bennett S, Humphreys J, Green M, Ledingham J. The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis. Rheumatol. Sept 18, 2018.
• Nikiphorou E, Negoescu A, Fitzpatrick JD, Goudie CT, Badcock A, Ostor AJ, Malaviya AP. Indispensible or intolerable? Methotrexate in rheumatoid and psoriatic arthritis: a retrospective review of discontinuation rates from a large UK cohort. J Rheumatol. 2014; 33 (5): 609-14
• (Research Collaboration) Malaviya AP, Ledingham J, et al. The 2013 BSR and BHPR guideline for the use of intravenous tocilizumab in the treatment of adult patients with rheumatoid arthritis. Rheumatology. 2014; 56(7):1344-6
• Malaviya AP, Ostor AJK. Drug adherence and compliance with biologic DMARDS with a special emphasis on the benefits of subcutaneous abatacept. Patient Pref Adherence. 2012.
• Malaviya AP, Ostor A. ‘The Harlequin Sign’. Benign blush or the bearer of bad news. Arthritis Rheum. 2012 Apr 5. doi: 10.1002/art.34487.
• Malaviya AP, Ostor AJ. Rheumatoid arthritis and the era of biologic therapy. Inflammopharmacology. 2012;20(2):59-69
• Malaviya AP, Hall FC. Targeting CVD in chronic connective tissue disease. Practitioner. 2012. 256(1747): 21-26
• Malaviya AP, Ostor AJ. Early diagnosis crucial in ankylosing spondylitis. Practitioner. 2011;255(1746): 21-24
• Malaviya AP, Dasgupta B. An approach to the diagnosis and assessment of childhood vasculitis. Indian J Paed (Rheumatology suppl). 2009.
• Burr ML, Malaviya AP, et al. Rituximab in Rheumatoid Arthritis following anti-TNF associated Tuberculosis. Rheumatol. 2008; 47: 738-739
• Patel AL, Malaviya AP, et al. Kerosene Poisoning- Varied Systemic Manifestations. JAPI. 52(1):65-66
• Patel AL, Malaviya AP, et al. Primary systemic amyloidosis. JAPI. 2004;52:335-7
• Patel AL, Malaviya AP, et al. Patent ductus arteriosus with a left to right shunt in a 64-year-old asymptomatic male. JAPI. 2004;52:753-5.

...

Prizes and awards

• Clinical Excellence Award, Mid Essex Hospital NHS Trust (2014)
• Best Clinical Research Team, NHS North Thames Regional CLRN Research Awards (2009)

Professional membership

• British Society of Rheumatology
• Fellow of Royal College of Physicians (London)

Languages spoken

English